Published in Int J Gen Med on July 21, 2010
Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries. Patient Prefer Adherence (2014) 0.75
Knowledge, attitudes, beliefs, values, preferences, and feasibility in relation to the use of injection safety devices in healthcare settings: a systematic review. Health Qual Life Outcomes (2016) 0.75
Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices. Occup Med (Lond) (2006) 1.48
Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia (2004) 1.24
Sharps injuries and bloodborne pathogen exposures in home health care. AAOHN J (2008) 1.06
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia (2008) 0.95
Strategies for preventing sharps injuries in the operating room. Surg Clin North Am (2005) 0.93
Review of standard precautions and sharps management in the community. Br J Community Nurs (2007) 0.92
Postmarketing surveillance study of KOGENATE Bayer with Bio-Set in patients with haemophilia A: evaluation of patients' satisfaction after switch to the new reconstitution system. Haemophilia (2009) 0.89
Incidence of parenterally transmitted acute viral hepatitis among healthcare workers in Italy. Infect Control Hosp Epidemiol (2007) 0.86
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) (2008) 2.23
Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update. Semin Thromb Hemost (2013) 2.19
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ (2011) 1.96
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med (2010) 1.83
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke (2002) 1.64
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol (2013) 1.63
Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus (2009) 1.62
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. J Thromb Haemost (2012) 1.57
How I treat rare venous thromboses. Blood (2008) 1.56
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica (2002) 1.54
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol (2011) 1.50
Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone (2006) 1.50
Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis (2006) 1.50
Effects on health of air pollution: a narrative review. Intern Emerg Med (2015) 1.48
The syndrome of the "obsessive-compulsory scientist": a new mental disorder? Clin Chem Lab Med (2013) 1.47
Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients. Intern Emerg Med (2013) 1.44
Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res (2009) 1.44
Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis (2007) 1.42
Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgery. Transfusion (2004) 1.42
Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab (2006) 1.41
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost (2009) 1.39
The growing impact of publications in haemostasis and thrombosis journals. Thromb Haemost (2007) 1.38
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy. Intern Emerg Med (2014) 1.38
The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta (2008) 1.33
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med (2010) 1.27
The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis (2010) 1.24
Prophylaxis in people with haemophilia. Thromb Haemost (2009) 1.19
Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med (2009) 1.19
An unusual case of a spurious, transfusion-acquired haemoglobin S. Blood Transfus (2010) 1.16
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev (2011) 1.15
Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol (2011) 1.15
Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost (2012) 1.15
Haemorrhage and amyloidosis. Br J Haematol (2012) 1.14
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol (2008) 1.12
Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med (2009) 1.11
Doping in competition or doping in sport? Br Med Bull (2008) 1.11
Influence of a light meal on routine haematological tests. Blood Transfus (2010) 1.10
Imatinib and regression of type 2 diabetes. N Engl J Med (2005) 1.09
The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med (2010) 1.06
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost (2010) 1.05
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance. Eur J Haematol Suppl (2008) 1.04
Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci (2006) 1.03
How to write a scientific manuscript for publication. Blood Transfus (2012) 1.02
Help me, Doctor! My D-dimer is raised. Ann Med (2008) 1.01
Mesenchymal stem cells: from biology to clinical use. Blood Transfus (2007) 1.00
Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost (2010) 1.00
Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? Semin Thromb Hemost (2010) 0.99
Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost (2010) 0.98
Identification of spurious hemolysis in anticoagulated blood with Sysmex XE-2100 and Siemens Advia 2120. Clin Lab (2012) 0.98
Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost (2010) 0.97
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. Haematologica (2007) 0.97
Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfus (2010) 0.96
Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J Lab Clin Med (2005) 0.96
Determinants of anaemia in the very elderly: a major contribution from impaired renal function? Blood Transfus (2010) 0.96
Haemophilia A: molecular insights. Clin Chem Lab Med (2007) 0.96
Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med (2011) 0.95
Diagnosis and management of ischemic heart disease. Semin Thromb Hemost (2013) 0.94
Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus (2009) 0.94
Old and new anticoagulant drugs: a minireview. Ann Med (2011) 0.94
Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues. Thromb Haemost (2009) 0.94
Inherited and acquired factor V deficiency. Blood Coagul Fibrinolysis (2011) 0.94
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia. Blood Transfus (2011) 0.94
Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis (2014) 0.94
Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future. J Thromb Thrombolysis (2010) 0.93
Safety of dental implant surgery in patients undergoing anticoagulation therapy: a prospective case-control study. Clin Oral Implants Res (2010) 0.93
Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis (2010) 0.93
TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med Sci Monit (2008) 0.92
Frequency and type of newly diagnosed haemoglobin variants in Northern Italy. Blood Transfus (2010) 0.92
Thromboembolism in childhood nephrotic syndrome: a rare but serious complication. Hematology (2007) 0.92
Bone mineral density in haemophilia patients. A meta-analysis. Thromb Haemost (2010) 0.91
Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus (2012) 0.91
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica (2008) 0.91
Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection. Blood Transfus (2011) 0.91
Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. Blood Transfus (2009) 0.91
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis (2006) 0.91
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev (2015) 0.90
Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost (2012) 0.90
Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls. Clin Chem Lab Med (2004) 0.90
Acquired haemophilia A as a blood transfusion emergency. Blood Transfus (2008) 0.90
The infectious burden in atherothrombosis. Semin Thromb Hemost (2012) 0.90
Intensive blood transfusion support in acquired hemophilia A. Ann Hematol (2006) 0.90
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med (2009) 0.89
Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev (2007) 0.89
Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges. Semin Thromb Hemost (2012) 0.89
Classic thrombophilic gene variants. Thromb Haemost (2015) 0.89
Acquired haemophilia a in the elderly: case reports. Curr Gerontol Geriatr Res (2010) 0.89
Homocysteine and arterial thrombosis: Challenge and opportunity. Thromb Haemost (2010) 0.89
Denaturing HPLC procedure for factor IX gene scanning. Clin Chem (2003) 0.88
Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. Semin Thromb Hemost (2011) 0.88
Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis. Diabetes Care (2007) 0.88
Blood doping by cobalt. Should we measure cobalt in athletes? J Occup Med Toxicol (2006) 0.87
C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med (2010) 0.87
ABO blood group and von Willebrand factor: biological implications. Clin Chem Lab Med (2014) 0.87
Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs. Thromb Haemost (2006) 0.87